No Data
Investor Optimism Abounds ChengDa Pharmaceuticals Co., Ltd. (SZSE:301201) But Growth Is Lacking
The entire pharmaceutical sector has surged sharply; what happened?
On Monday, all AH Stocks in the pharmaceutical Sector surged, with innovative drugs performing the strongest. The Yinhua CSI Innovative Drugs Industry ETF collectively rose sharply, driven by three main factors: the relaxation of collective procurement, overseas license authorizations, and improvement in Earnings Reports that will reshape the Industry landscape.
The opening dominates the screen! The strongest new main line in the second quarter.
Funds are quickly being amassed.
Funds are being frantically invested, and pharmaceutical stocks are back in the spotlight! Bullish policies and fundamentals have arrived.
Performance is steadily increasing.
The "wind" has reached the pharmaceutical stocks, and the Sector is experiencing a surge in limit-up prices! What are the Bullish catalysts?
Catalysts from news, warming performance, and the advantages of valuation may become the main factors boosting the rise of pharmaceutical stocks.
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.